Prevalence of prolonged QTc interval among HIV infected patients on highly active antiretroviral therapy (HAART) and its relationship with cd4 cells count and viral load at a tertiary hospital in North Eastern Nigeria.
Main Article Content
Keywords
QTc interval, HIV, Highly Active Antiretroviral Therapy, CD4 cell count , Viral Load
Abstract
Background: Patients living with HIV infection remain at increased risk of cardiovascular diseases and sudden cardiac death. Various prevalence of electrocardiographic (ECG) abnormalities among HIV-infected patients were reported: Attamah et al reported the prevalence of electrocardiographic abnormalities among HIV-infected patients as 34.5%, while Orunta et al reported a prevalence of 42.9%, and Njoku et al reported a prevalence of 93.0%. Human immunodeficiency virus-infected patients are at increased risk of developing prolonged QT interval. Sani et al reported the prevalence of prolonged corrected QT interval among HIV-infected patients as 45.0%. Innocent et al reported a prevalence of48.0%, while Ajala et al reported a prevalence of 18%. Prolonged QTc interval increases the risk of premature ventricular contraction which can degenerate into ventricular tachycardia and or ventricular that can result in sudden cardiac death.
Methodology: The study was a cross-sectional conducted among HIV-infected patients receiving HAART at the Federal Medical Centre Nguru, Yobe State, North Eastern Nigeria.
Results: One hundred and seven (107) subjects were recruited into the study comprising thirty-three (37.0%) males and 70(65.4%) females. The mean CD4 cell count, and viral load of the studied patients were 612.64±34.75 cells/μL and 4646.30±58.68 copies/mL respectively. Twenty (18.7%) patients had prolonged QTc interval, this gave us the prevalence of prolonged QTc in this study as 18.7%. The commonest cardiac rhythm was sinus rhythm (69.2%), followed by sinus tachycardia (26.2%) and atrial fibrillation 5(4.7%). Other electrocardiographic findings include First-degree atrioventricular block was seen in seven (6.5%) patients, Premature ventricular contractions were found in16.8%, RBBB was observed in 2.8%, 3.7% of patients had LBBB and 4.7% had left posterior hemiblock. The distribution of QTc interval according to CD4 cells count and viral revealed a statistically significant difference across the groups. All the patients with prolonged QTc interval had lower CD4 cells count and higher viral load suggesting that HIV disease severity is associated with prolonged QTc interval.
Conclusion: In conclusion, the study revealed that the prevalence of prolonged QTc interval among HIV infected patients on highly active antiretroviral therapy was found to be 18.7%, and that HIV disease severity increases the risk of developing prolonged QTc interval.
References
2 Onovo AA, Adeyemi A, Onime D, Kalnoky M, Kagniniwa B, Dessie M, et`al. Estimation of HIV prevalence and burden in Nigeria: a Bayesian predictive modelling study. eClinicalMedicine2023;62: 102098 https://doi.org/10. 1016/j.eclinm.2023. 102098. Access date 4th March 2024
3 Hemkens LG, Bucher HC. HIV infection and cardiovascular disease. Eur Heart J 2014; 35:1373–1381
4 Attamah CA, Sadoh WE, Ibadin MO and Omoigberale AI. Electrocardiographic findings in human immunodeficiency virus-infected children in Benin City, Nigeria. Niger Postgrad Med J 2020; 27:357-364
5 Orunta CP, Ibeneme CA, Ogbonna IF, Ukaegbu U and Otaigbe BE. Electrocardiographic abnormalities in children with human immunodeficiency virus infection presenting to the federal medical centre, Umuahia, South-east Nigeria. Niger J Med 2023; 32:375-381
6 Njoku PO, Ejim EC, Anisiuba BC, Ike SO, Onwubere BJC. Electrocardiographic findings in a cross-sectional study of human immunodeficiency virus (HIV) patients in Enugu, south-east Nigeria. Cardiovascular journal of Africa 2016;27(4):252-257
7 Sani MU, Okeahialam BN. QTc interval prolongation in patients with HIV and AIDS. J Natl Med Assoc. 2005;97(12):1657-1661.
8 Okoye IC, Ernest Anyabolu N. Electrocardiographic abnormalities in treatment-naïve HIV subjects in south-east Nigeria. Cardiovascular Journal of Africa 2017;28(5):315- 318
9 Ajala OA, Akpa MR, Dodiyi-Manuel S. Pattern of Electrocardiographic and Echocardiographic Abnormalities Among HIV Patients in Port Harcourt, Nigeria. International Journal of HIV/AIDS Prevention, Education and Behavioral Science. 2020;6(1):15-24
10 Drew BJ, Ackerman MJ, Funk M, Gibler WB, Kligfield P, Menon V, et al. Prevention of torsade de pointes in hospital settings: a scientific statement from the American heart association and the American college of cardiology foundation. J Am Coll Cardiol. (2010) 55(9):934–947. doi: 10.1016/j.jacc.2010.01.001
11 Elming H, Holm E, Jun L, Torppederson C, Kober L, Kircshoff M et al. The prognostic value of the QT interval and QT interval dispersion in all-cause and cardiac mortality and morbidity in a population of Danish citizens. Eur Heart J. 1998; 19:1391-1400.
12 Tseng ZH, Secemsky EA, Dowdy D, Vittinghoff E, Moyers B, Wong JK, et al. Sudden cardiac death in patients with human immunodeficiency virus infection. J Am Coll Cardiol. 2012;59: 1891-1896
13 Reinsch N, Buhr C, Krings P, Kaelsch H, Neuhaus K, Wieneke H, et al. German Heart Failure Network. Prevalence and risk factors of prolonged QTc interval in HIV-infected patients: results of the HIV-HEART study. HIV Clin Trials. 2009;10(4):261-268
14 Qaqa AY, Shaaban H, DeBari VA, Phung S, Slim J, Costeas CA, et al. Viral load and CD4 cell count as risk factors for prolonged QT interval in HIV-infected subjects: a cohort-nested case-control study in an outpatient population. Cardiology. 2010;117(2): 105-111.
15 Kocheril AG, Bokhari SA, Batsford WP, Sinusas AJ. Long QTc and torsades de pointes in human immunodeficiency virus disease. Pacing Clin Electrophysiol. 1997;20(11):2810-2816.
16 El-Sherif N, Turitto G. Electrolyte disorders and arrhythmogenesis. Cardiol J. 2011; 18(3): 233‐245
17 Anson BD, Weaver JG, Ackerman MJ, Akinsete O, Henry K, January CT, et al. Blockade of HERG channels by HIV protease inhibitors. Lancet 2005; 365:682e6.
18 Chinello P,Lisena FP, Angeletti C, Boumis E, Papetti F, Petrosillo N. Role of antiretroviral treatment in prolonging QTc interval in HIV-positive patients. J Infect. 2007Jun;54(6):597-602
19 Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron.1976;16(1):31-41
20 Bazett HC. An analysis of the time-relations of electrocardiograms. Heart. 1920; 7:353-370
21 Semba RD, Gray GE. Pathogenesis of anaemia during human immunodeficiency virus infection. J Investig Med. 2001; 49:225-239.
22 Kooij KW, Vogt L, Wit FWNM, van der Valk M, van Zoest RA, Goorhuis A, et’al. AGE HIV Cohort Study. Higher prevalence and faster progression of chronic kidney disease in human immunodeficiency virus-infected middle-aged individuals compared with human immunodeficiency virus uninfected controls. J Infect Dis. 2017;216(6):622-631.
23 Shaaban H, Qaqa A, Slim J, Perez G. The role of HIV Viral Load and CD4 Cell Count in the prolongation of the QT interval in patients from an HIV outpatient clinic. Int J Infect Dis. 2010;14(SUPPL. 1): e79.
24 Gili S, Mancone M, Ballocca F, Grosso Marra W, Calcagno A, D`Ettorre G, et al. Prevalence and predictors of long corrected QT interval in HIV-positive patients: a multicenter study. J Cardiovasc Med (Hagerstown). 2017;18(7):539-544
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
This is an open-access journal and articles are distributed under the terms of the Creative Commons Attribution Non-Commercial Share-Alike License 4.0. This licence allows users to download and share, remix, tweak and build upon the article for non-commercial purposes, so long as the original authorship is acknowledged and the new creations are licensed under identical terms.